EVH — Evolent Health Cashflow Statement
0.000.00%
Last trade - 00:00
- $2.29bn
- $2.72bn
- $1.96bn
- 56
- 58
- 57
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -306 | -334 | -37.6 | -19.2 | -113 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 225 | 313 | 30.5 | 44.5 | 125 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.331 | -55.3 | -13.6 | -58.5 | 100 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -42.6 | -16.2 | 38.7 | -11.6 | 143 |
Capital Expenditures | -35.5 | -31.8 | -25 | -47.5 | -28.7 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -146 | 293 | 9.2 | -212 | -387 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -182 | 261 | -15.8 | -259 | -416 |
Financing Cash Flow Items | -106 | -27.9 | 56 | -92.7 | -63.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -35.5 | -11.9 | -29.5 | 132 | 281 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -260 | 233 | -6.64 | -140 | 8.3 |